Standard BioTools
LAB
LAB
99 hedge funds and large institutions have $422M invested in Standard BioTools in 2018 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 39 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
45% more capital invested
Capital invested by funds: $291M → $422M (+$131M)
25% more funds holding
Funds holding: 79 → 99 (+20)
2.26% more ownership
Funds ownership: 99.23% → 101.5% (+2.3%)
Holders
99
Holding in Top 10
3
Calls
$288K
Puts
$17K
Top Buyers
| 1 | +$19.9M | |
| 2 | +$8.01M | |
| 3 | +$7.67M | |
| 4 |
RI
RTW Investments
New York
|
+$7.62M |
| 5 |
Primecap Management
Pasadena,
California
|
+$7.03M |
Top Sellers
| 1 | -$8.07M | |
| 2 | -$5.47M | |
| 3 | -$2.81M | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$794K |
| 5 |
FAM
Fred Alger Management
New York
|
-$285K |